Houston, Texas
Cancer clinical trials in Houston, TX
624 cancer studies are recruiting participants at sites in Houston as of November 16, 2026, according to ClinicalTrials.gov. Oncology Research Hub can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Houston at a glance
- 624 studies are recruiting at a site in Houston.
- By phase: Early Phase 1 (2), Phase 1 (140), Phase 1/2 (131), Phase 2 (130), Phase 2/3 (11), Phase 3 (100), Phase 4 (4), No phase (44), Observational (62). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (355), university, hospital or other (248), government (21).
- By research area: Breast Cancer (180), Lung Cancer (179), Lymphoma (129), Prostate Cancer (64), Pancreatic Cancer (38), Melanoma (34).
- Most recent update to one of these records: November 16, 2026.
Breast cancer studies recruiting in Houston
Basic details from each study's public record (the 30 most recently updated of 624). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Improving Comprehensive Care of Cancer Patients
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Baylor College of Medicine
- Study site
- Baylor College of Medicine
- Registry record
- NCT05323409 · updated
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Study sites
- The Methodist Hospital Research Institute · The University of Texas MD Anderson Cancer Center
- Registry record
- NCT06324357 · updated
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- LeonaBio
- Study sites
- Baylor College of Medicine · Harris Health System - Smith Clinic · MD Anderson Cancer Center
- Registry record
- NCT05696626 · updated
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- Next Oncology - Houston
- Registry record
- NCT07488676 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Houston, TX on ClinicalTrials.gov.
Lung cancer studies recruiting in Houston
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- NovoCure GmbH
- Study site
- Houston Methodist Cancer Center
- Registry record
- NCT06216301 · updated
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
- Phase 1/2
- Ages 18 to 75
- All sexes
- Sponsor
- Tyligand Pharmaceuticals (Suzhou) Limited
- Study site
- MD Anderson Cancer Center
- Registry record
- NCT06385925 · updated
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 to 99
- All sexes
- Sponsor
- Erasca, Inc.
- Study site
- The University of Texas MD Anderson Cancer Center
- Registry record
- NCT06983743 · updated
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Study sites
- MD Anderson · NEXT Oncology Houston
- Registry record
- NCT07277413 · updated
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- University of Texas-MD Anderson Cancer Center ( Site 3283)
- Registry record
- NCT07513376 · updated
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Phase 3
- Ages 18 to 100
- All sexes
- Sponsor
- Amgen
- Study sites
- Oncology Consultants PA · University of Texas MD Anderson Cancer Center
- Registry record
- NCT05920356 · updated
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Novelty Nobility, Inc.
- Study site
- The University of Texas MD Anderson Cancer Center
- Registry record
- NCT06805825 · updated
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- University of Texas MD Anderson Cancer Center
- Registry record
- NCT07063745 · updated
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- BioNTech SE
- Study site
- University of Texas M. D. Anderson Cancer Center
- Registry record
- NCT07111520 · updated
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Study site
- MD Anderson Cancer Center
- Registry record
- NCT07659782 · updated
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Houston Methodist Hospital · Houston Methodist West Hospital
- Registry record
- NCT04267848 · updated
Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers
- Observational
- All ages
- All sexes
- Sponsor
- Lung Cancer Mutation Consortium
- Study site
- Baylor College of Medicine
- Registry record
- NCT04712877 · updated
Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Study site
- The University of Texas MD Anderson Cancer Center
- Registry record
- NCT04886804 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Houston, TX on ClinicalTrials.gov.
Prostate cancer studies recruiting in Houston
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Texas Oncology - Gulf Coast ( Site 8002)
- Registry record
- NCT06136624 · updated
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Amgen
- Study site
- University of Texas MD Anderson Cancer Center
- Registry record
- NCT04221542 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Houston, TX on ClinicalTrials.gov.
Melanoma studies recruiting in Houston
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- M.D. Anderson Cancer Center
- Study site
- M D Anderson Cancer Center
- Registry record
- NCT04751396 · updated
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
- No phase
- Ages 19 and older
- All sexes
- Sponsor
- M.D. Anderson Cancer Center
- Study site
- M D Anderson Cancer Center
- Registry record
- NCT05053555 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Houston, TX on ClinicalTrials.gov.
Lymphoma studies recruiting in Houston
Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- M.D. Anderson Cancer Center
- Study site
- M D Anderson Cancer Center
- Registry record
- NCT05011045 · updated
Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- M.D. Anderson Cancer Center
- Study site
- MD Anderson Cancer Center
- Registry record
- NCT05676450 · updated
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Houston Methodist Cancer Center ( Site 0154)
- Registry record
- NCT06717347 · updated
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
- Phase 1/2
- Ages 12 and older
- All sexes
- Sponsor
- AstraZeneca
- Registry record
- NCT07109219 · updated
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- University of Texas-MD Anderson Cancer Center ( Site 1323)
- Registry record
- NCT07634471 · updated
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Phase 2
- Ages 1 to 30
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center · UT MD Anderson Cancer Center
- Registry record
- NCT04546399 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Houston, TX on ClinicalTrials.gov.
Pancreatic cancer studies recruiting in Houston
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Phase 2
- Ages 12 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- University of Texas MD Anderson Cancer Center ( Site 0112)
- Registry record
- NCT04924075 · updated
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Incyte Corporation
- Study site
- Investigative Site US011
- Registry record
- NCT07522073 · updated
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Study site
- MD Anderson Cancer Center
- Registry record
- NCT07644559 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Houston, TX on ClinicalTrials.gov.
Ask about studies near Houston
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Texas
All Texas locations
894 studies recruiting across 75 cities.
Dallas
243 studies recruiting.
San Antonio
195 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Oncology Research Hub does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections